Astrocyte-derived VEGF-A drives blood-brain barrier disruption in CNS inflammatory disease.

In inflammatory CNS conditions such as multiple sclerosis (MS), current options to treat clinical relapse are limited, and more selective agents are needed. Disruption of the blood-brain barrier (BBB) is an early feature of lesion formation that correlates with clinical exacerbation, leading to edema, excitotoxicity, and entry of serum proteins and inflammatory cells. Here, we identify astrocytic expression of VEGF-A as a key driver of BBB permeability in mice. Inactivation of astrocytic Vegfa expression reduced BBB breakdown, decreased lymphocyte infiltration and neuropathology in inflammatory and demyelinating lesions, and reduced paralysis in a mouse model of MS. Knockdown studies in CNS endothelium indicated activation of the downstream effector eNOS as the principal mechanism underlying the effects of VEGF-A on the BBB. Systemic administration of the selective eNOS inhibitor cavtratin in mice abrogated VEGF-A-induced BBB disruption and pathology and protected against neurologic deficit in the MS model system. Collectively, these data identify blockade of VEGF-A signaling as a protective strategy to treat inflammatory CNS disease.

[1]  Benjamin D. Sachs,et al.  Fibrinogen inhibits neurite outgrowth via β3 integrin-mediated phosphorylation of the EGF receptor , 2007, Proceedings of the National Academy of Sciences.

[2]  Giuseppe Cirino,et al.  Endothelial nitric oxide synthase: the Cinderella of inflammation? , 2003, Trends in pharmacological sciences.

[3]  Karin E. Sandoval,et al.  Blood-brain barrier tight junction permeability and ischemic stroke , 2008, Neurobiology of Disease.

[4]  G. Semenza,et al.  Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1 , 1996, Molecular and cellular biology.

[5]  R. Deane,et al.  ALS-causing SOD1 mutants generate vascular changes prior to motor neuron degeneration , 2008, Nature Neuroscience.

[6]  Leon Lagnado,et al.  The retina , 1999, Current Biology.

[7]  R. Groszmann,et al.  Selective inhibition of tumor microvascular permeability by cavtratin blocks tumor progression in mice. , 2003, Cancer cell.

[8]  V. Yong,et al.  Metalloproteinases: Mediators of Pathology and Regeneration in the CNS , 2005, Nature Reviews Neuroscience.

[9]  B. Barres,et al.  Pericytes are required for blood–brain barrier integrity during embryogenesis , 2010, Nature.

[10]  M. Sofroniew.  Molecular dissection of reactive astrogliosis and glial scar formation , 2009, Trends in Neurosciences.

[11]  Clive N Svendsen,et al.  Leukocyte Infiltration, Neuronal Degeneration, and Neurite Outgrowth after Ablation of Scar-Forming, Reactive Astrocytes in Adult Transgenic Mice , 1999, Neuron.

[12]  E. Oldfield,et al.  Vascular Endothelial Growth Factor Is Expressed in Multiple Sclerosis Plaques and Can Induce Inflammatory Lesions in Experimental Allergic Encephalomyelitis Rats , 2002, Journal of neuropathology and experimental neurology.

[13]  M. Mcdaniel,et al.  Experimental allergic encephalomyelitis in the rat is inhibited by aminoguanidine, an inhibitor of nitric oxide synthase , 1996, Journal of Neuroimmunology.

[14]  K. Kimura,et al.  Hypoxia promotes fibrogenesis in vivo via HIF-1 stimulation of epithelial-to-mesenchymal transition. , 2007, The Journal of clinical investigation.

[15]  D. Cheresh,et al.  Pathophysiological consequences of VEGF-induced vascular permeability , 2005, Nature.

[16]  Hans Lassmann,et al.  Inflammatory central nervous system demyelination: Correlation of magnetic resonance imaging findings with lesion pathology , 1997, Annals of neurology.

[17]  F. Hayot,et al.  Proapoptotic and Antiapoptotic Actions of Stat1 versus Stat3 Underlie Neuroprotective and Immunoregulatory Functions of IL-11 , 2011, The Journal of Immunology.

[18]  S. Liebner,et al.  Claudin-1 and claudin-5 expression and tight junction morphology are altered in blood vessels of human glioblastoma multiforme , 2000, Acta Neuropathologica.

[19]  C. Brosnan,et al.  IL-1β Regulates Blood-Brain Barrier Permeability via Reactivation of the Hypoxia-Angiogenesis Program1 , 2006, The Journal of Immunology.

[20]  M. Sofroniew,et al.  GFAP-expressing progenitors are the principal source of constitutive neurogenesis in adult mouse forebrain , 2004, Nature Neuroscience.

[21]  V. Yong,et al.  Interleukin-1 (cid:98) is Required for the Early Evolution of Reactive Astrogliosis Following CNS Lesion , 2001 .

[22]  F. Lublin,et al.  Multiple sclerosis: new treatment trials and emerging therapeutic targets , 2008, Current opinion in neurology.

[23]  F. Charron,et al.  The Hedgehog Pathway Promotes Blood-Brain Barrier Integrity and CNS Immune Quiescence , 2011, Science.

[24]  S. Tsirka,et al.  Endothelial NOS‐deficient mice reveal dual roles for nitric oxide during experimental autoimmune encephalomyelitis , 2009, Glia.

[25]  R. D. Rudic,et al.  In vivo delivery of the caveolin-1 scaffolding domain inhibits nitric oxide synthesis and reduces inflammation , 2000, Nature Medicine.

[26]  M Aguet,et al.  VEGF is required for growth and survival in neonatal mice. , 1999, Development.

[27]  F. Angileri,et al.  NMDA receptor antagonist felbamate reduces behavioral deficits and blood-brain barrier permeability changes after experimental subarachnoid hemorrhage in the rat. , 2007, Journal of neurotrauma.

[28]  R. Klein,et al.  CXCL12 Limits Inflammation by Localizing Mononuclear Infiltrates to the Perivascular Space during Experimental Autoimmune Encephalomyelitis1 , 2006, The Journal of Immunology.

[29]  G. Comi,et al.  A short-term randomized MRI study of high-dose oral vs intravenous methylprednisolone in MS , 2009, Neurology.

[30]  D. Anthony,et al.  Inflammatory cytokines, angiogenesis, and fibrosis in the rat peritoneum. , 2002, The American journal of pathology.

[31]  C. Achim,et al.  Blood-brain barrier tight junction disruption in human immunodeficiency virus-1 encephalitis. , 1999, The American journal of pathology.

[32]  R. Ransohoff,et al.  Astrocyte-restricted ablation of interleukin-17-induced Act1-mediated signaling ameliorates autoimmune encephalomyelitis. , 2010, Immunity.

[33]  S. Moncada,et al.  Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo , 1990, British journal of pharmacology.

[34]  V. Perry,et al.  Reversible demyelination, blood-brain barrier breakdown, and pronounced neutrophil recruitment induced by chronic IL-1 expression in the brain. , 2004, The American journal of pathology.

[35]  W. Sessa,et al.  Dissecting the molecular control of endothelial NO synthase by caveolin-1 using cell-permeable peptides. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[36]  Christopher J. Robinson,et al.  The splice variants of vascular endothelial growth factor (VEGF) and their receptors. , 2001, Journal of cell science.

[37]  R. Keep,et al.  Potential role of MCP-1 in endothelial cell tight junction `opening': signaling via Rho and Rho kinase , 2003, Journal of Cell Science.

[38]  H. Weiner,et al.  A monoclonal antibody against a myelin oligodendrocyte glycoprotein induces relapses and demyelination in central nervous system autoimmune disease. , 1987, Journal of immunology.

[39]  D. Herr,et al.  FTY720 (fingolimod) efficacy in an animal model of multiple sclerosis requires astrocyte sphingosine 1-phosphate receptor 1 (S1P1) modulation , 2010, Proceedings of the National Academy of Sciences.

[40]  B. Zlokovic.  The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders , 2008, Neuron.

[41]  L. Claesson‐Welsh,et al.  VEGF receptor signalling ? in control of vascular function , 2006, Nature Reviews Molecular Cell Biology.

[42]  Lisa E. Gralinski,et al.  Mouse Adenovirus Type 1-Induced Breakdown of the Blood-Brain Barrier , 2009, Journal of Virology.

[43]  Kenneth J. Hillan,et al.  Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene , 1996, Nature.

[44]  Berislav V. Zlokovic,et al.  Pericytes Control Key Neurovascular Functions and Neuronal Phenotype in the Adult Brain and during Brain Aging , 2010, Neuron.

[45]  Lieve Moons,et al.  Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele , 1996, Nature.

[46]  Bengt R. Johansson,et al.  Pericytes regulate the blood–brain barrier , 2010, Nature.

[47]  Hiroshi Yamamoto,et al.  Induction of various blood‐brain barrier properties in non‐neural endothelial cells by close apposition to co‐cultured astrocytes , 1997, Glia.

[48]  A. Mildner,et al.  IkappaB kinase 2 determines oligodendrocyte loss by non-cell-autonomous activation of NF-kappaB in the central nervous system. , 2011, Brain : a journal of neurology.

[49]  A. T. Argaw,et al.  VEGF-mediated disruption of endothelial CLN-5 promotes blood-brain barrier breakdown , 2009, Proceedings of the National Academy of Sciences.

[50]  T. Davis,et al.  The Blood-Brain Barrier/Neurovascular Unit in Health and Disease , 2005, Pharmacological Reviews.

[51]  F. Sánchez‐Madrid,et al.  Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha 4 beta 1 integrin. , 1992, Nature.

[52]  R. Johnson,et al.  Astrocyte hypoxic response is essential for pathological but not developmental angiogenesis of the retina , 2010, Glia.

[53]  B. Engelhardt,et al.  Altered vascular permeability and early onset of experimental autoimmune encephalomyelitis in PECAM-1-deficient mice. , 2002, The Journal of clinical investigation.

[54]  T. Noda,et al.  Occludin-deficient Embryonic Stem Cells Can Differentiate into Polarized Epithelial Cells Bearing Tight Junctions , 1998, The Journal of cell biology.

[55]  S. Tsukita,et al.  Size-selective loosening of the blood-brain barrier in claudin-5–deficient mice , 2003, The Journal of cell biology.

[56]  H. Lassmann,et al.  The fibrin-derived γ377-395 peptide inhibits microglia activation and suppresses relapsing paralysis in central nervous system autoimmune disease , 2007, The Journal of experimental medicine.

[57]  W. Ski,et al.  Increased blood-brain barrier permeability and endothelial abnormalities induced by vascular endothelial growth factor , 1998 .

[58]  B. Engelhardt,et al.  Localization of claudin-3 in tight junctions of the blood-brain barrier is selectively lost during experimental autoimmune encephalomyelitis and human glioblastoma multiforme , 2003, Acta Neuropathologica.

[59]  S. Reingold,et al.  The role of magnetic resonance techniques in understanding and managing multiple sclerosis. , 1998, Brain : a journal of neurology.

[60]  T. Moran,et al.  IL-11 Regulates Autoimmune Demyelination1 , 2009, The Journal of Immunology.